PLEASANTON, Calif., Aug. 2 /PRNewswire-FirstCall/ -- Thoratec Corporation , a world leader in products to treat cardiovascular disease, said today that it will be participating in the Canaccord Adams 2006 Summer Seminar on Tuesday, August 8.
Gary F. Burbach, president and chief executive officer, will provide an update on the company, beginning at 8 a.m., Eastern Daylight Time (5 a.m., Pacific Daylight Time).
The presentation will be available through the conference web site at http://www.corporate-ir.net/ireye/conflobby.zhtml?ticker=THOR&item_id1351834 and also on the company’s web site http://www.thoratec.com .
Thoratec is a world leader in therapies to address advanced stage heart failure. The company’s product line includes the Thoratec(R) VAD (Ventricular Assist Device) and HeartMate(R) LVAS (Left Ventricular Assist System) with more than 10,000 devices implanted in patients suffering from heart failure. Additionally, its International Technidyne Corporation (ITC) division supplies blood testing and skin incision products. Thoratec is headquartered in Pleasanton, California. For more information, visit the company’s web sites at http://www.thoratec.com or http://www.itcmed.com .
Thoratec Corporation
CONTACT: Cynthia Lucchese, Senior Vice President, Chief Financial Officerof Thoratec Corporation, +1-925-847-8600, or Neal Rosen of Kalt Rosen &Co., +1-415-397-2686, for Thoratec Corporation
Web site: http://www.thoratec.com/
